VYGR logo

Voyager Therapeutics (VYGR) CAPEX

Annual CAPEX

$3.26 M
+$765.00 K+30.71%

December 31, 2023

Summary

Performance

1-Year Change

+30.71%

3-Year Change

-73.08%

5-Year Change

-24.37%

15-Year Change

-18.29%

VYGR CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.49%
VYGR annual capital expenditures is higher than 50.49% of companies in Healthcare sector

High & Low

All-time High

$12.10 M
VYGR annual capital expenditures is currently -73.08% below its historical high of $12.10 million

3-Year Low

$1.61 M
VYGR annual capital expenditures is currently +102.36% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VYGR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
VYGR next annual earnings announcement is scheduled for Feb 28, 2025

OtherVYGRcash flowmetrics:

Annual FCF

$74.66 M
VYGR annual free cash flow is $74.66 million

Annual CFO

$77.92 M
VYGR annual cash flow from operations is $77.92 million

Annual CFI

-$141.64 M
VYGR annual cash flow from investing activities is -$141.64 million

Annual CFF

$33.65 M
VYGR annual cash flow from financing activities is $33.65 million

Quarterly CAPEX

$258.00 K
-$709.00 K-73.32%

September 30, 2024

Summary

Performance

3-Month Change

-73.32%

1-Year Change

-65.83%

3-Year Change

-72.35%

5-Year Change

-72.35%

VYGR Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.12%
VYGR quarterly capital expenditures is higher than 39.12% of companies in Healthcare sector

High & Low

All-time High

$5.15 M
VYGR quarterly capital expenditures is currently -94.99% below its historical high of $5.15 million

3-Year Low

$38.00 K
VYGR quarterly capital expenditures is currently +578.95% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VYGR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VYGR next earnings announcement is scheduled for Feb 28, 2025

OtherVYGRcash flowmetrics:

Quarterly FCF

-$28.23 M
VYGR quarterly free cash flow is -$28.23 million

Quarterly CFO

-$27.97 M
VYGR quarterly cash flow from operations is -$27.97 million

Quarterly CFI

$64.35 M
VYGR quarterly cash flow from investing activities is $64.35 million

Quarterly CFF

$14.00 K
VYGR quarterly cash flow from financing activities is $14.00 thousand

TTM CAPEX

$4.12 M
-$524.00 K-11.28%

September 30, 2024

Summary

Performance

3-Month Change

-11.28%

1-Year Change

+26.57%

3-Year Change

+65.44%

5-Year Change

+65.44%

VYGR TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.35%
VYGR TTM capital expenditures is higher than 52.35% of companies in Healthcare sector

High & Low

All-time High

$12.10 M
VYGR TTM capital expenditures is currently -65.93% below its historical high of $12.10 million

3-Year Low

$1.27 M
VYGR TTM capital expenditures is currently +223.98% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VYGR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VYGR next earnings announcement is scheduled for Feb 28, 2025

OtherVYGRcash flowmetrics:

TTM FCF

-$28.66 M
VYGR TTM free cash flow is -$28.66 million

TTM CFO

-$24.54 M
VYGR TTM cash flow from operations is -$24.54 million

TTM CFI

-$40.82 M
VYGR TTM cash flow from investing activities is -$40.82 million

TTM CFF

$113.90 M
VYGR TTM cash flow from financing activities is $113.90 million

VYGR CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.7%-65.8%+26.6%
3 y3 years-73.1%-72.3%+65.4%
5 y5 years-24.4%-72.3%+65.4%

VYGR CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+102.4%-88.0%+579.0%-15.7%+224.0%
5 y5-year-73.1%+102.4%-95.0%+579.0%-65.9%+224.0%
alltimeall time-73.1%+216.1%-95.0%+579.0%-65.9%+2647.3%

Voyager Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$258.00 K(-73.3%)
$4.12 M(-11.3%)
Jun 2024
-
$967.00 K(-54.8%)
$4.64 M(-5.0%)
Mar 2024
-
$2.14 M(+183.6%)
$4.89 M(+50.1%)
Dec 2023
$3.26 M(+30.7%)
$755.00 K(-3.5%)
$3.26 M(-5.2%)
Sep 2023
-
$782.00 K(-35.4%)
$3.43 M(+17.2%)
Jun 2023
-
$1.21 M(+137.7%)
$2.93 M(-1.1%)
Mar 2023
-
$509.00 K(-45.4%)
$2.96 M(+18.9%)
Dec 2022
$2.49 M(+54.8%)
$933.00 K(+235.6%)
$2.49 M(+30.8%)
Sep 2022
-
$278.00 K(-77.6%)
$1.91 M(-16.7%)
Jun 2022
-
$1.24 M(+3168.4%)
$2.29 M(+79.8%)
Mar 2022
-
$38.00 K(-89.0%)
$1.27 M(-20.9%)
Dec 2021
$1.61 M(-86.7%)
$347.00 K(-47.4%)
$1.61 M(-66.6%)
Sep 2021
-
$660.00 K(+190.7%)
$4.82 M(-48.2%)
Jun 2021
-
$227.00 K(-39.5%)
$9.31 M(-15.1%)
Mar 2021
-
$375.00 K(-89.5%)
$10.96 M(-9.4%)
Dec 2020
$12.10 M(+56.7%)
$3.56 M(-31.0%)
$12.10 M(+1.5%)
Sep 2020
-
$5.15 M(+173.8%)
$11.92 M(+50.1%)
Jun 2020
-
$1.88 M(+24.9%)
$7.94 M(-2.2%)
Mar 2020
-
$1.51 M(-55.4%)
$8.12 M(+5.2%)
DateAnnualQuarterlyTTM
Dec 2019
$7.72 M(+79.3%)
$3.38 M(+187.6%)
$7.72 M(+58.6%)
Sep 2019
-
$1.17 M(-43.1%)
$4.87 M(+7.2%)
Jun 2019
-
$2.06 M(+87.0%)
$4.54 M(+19.4%)
Mar 2019
-
$1.10 M(+111.1%)
$3.80 M(-11.7%)
Dec 2018
$4.30 M(+8.0%)
$523.00 K(-38.4%)
$4.30 M(+9.2%)
Sep 2018
-
$849.00 K(-36.0%)
$3.94 M(+12.5%)
Jun 2018
-
$1.33 M(-17.5%)
$3.51 M(+32.5%)
Mar 2018
-
$1.61 M(+898.1%)
$2.65 M(-33.6%)
Dec 2017
$3.98 M(-20.8%)
$161.00 K(-60.9%)
$3.98 M(-48.2%)
Sep 2017
-
$412.00 K(-11.8%)
$7.69 M(-1.2%)
Jun 2017
-
$467.00 K(-84.1%)
$7.78 M(+3.6%)
Mar 2017
-
$2.94 M(-23.9%)
$7.51 M(+49.4%)
Dec 2016
$5.03 M(+388.3%)
$3.87 M(+669.2%)
$5.03 M(+292.6%)
Sep 2016
-
$503.00 K(+155.3%)
$1.28 M(+23.5%)
Jun 2016
-
$197.00 K(-57.2%)
$1.04 M(-22.6%)
Mar 2016
-
$460.00 K(+280.2%)
$1.34 M(+30.1%)
Dec 2015
$1.03 M
$121.00 K(-53.3%)
$1.03 M(+13.3%)
Sep 2015
-
$259.00 K(-48.2%)
$909.00 K(+39.8%)
Jun 2015
-
$500.00 K(+233.3%)
$650.00 K(+333.3%)
Mar 2015
-
$150.00 K
$150.00 K

FAQ

  • What is Voyager Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Voyager Therapeutics?
  • What is Voyager Therapeutics annual CAPEX year-on-year change?
  • What is Voyager Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Voyager Therapeutics?
  • What is Voyager Therapeutics quarterly CAPEX year-on-year change?
  • What is Voyager Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Voyager Therapeutics?
  • What is Voyager Therapeutics TTM CAPEX year-on-year change?

What is Voyager Therapeutics annual capital expenditures?

The current annual CAPEX of VYGR is $3.26 M

What is the all time high annual CAPEX for Voyager Therapeutics?

Voyager Therapeutics all-time high annual capital expenditures is $12.10 M

What is Voyager Therapeutics annual CAPEX year-on-year change?

Over the past year, VYGR annual capital expenditures has changed by +$765.00 K (+30.71%)

What is Voyager Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of VYGR is $258.00 K

What is the all time high quarterly CAPEX for Voyager Therapeutics?

Voyager Therapeutics all-time high quarterly capital expenditures is $5.15 M

What is Voyager Therapeutics quarterly CAPEX year-on-year change?

Over the past year, VYGR quarterly capital expenditures has changed by -$497.00 K (-65.83%)

What is Voyager Therapeutics TTM capital expenditures?

The current TTM CAPEX of VYGR is $4.12 M

What is the all time high TTM CAPEX for Voyager Therapeutics?

Voyager Therapeutics all-time high TTM capital expenditures is $12.10 M

What is Voyager Therapeutics TTM CAPEX year-on-year change?

Over the past year, VYGR TTM capital expenditures has changed by +$865.00 K (+26.57%)